OCR Text |
Show Journal of Neuro- Ophthalmology 19: 278- 281 © 1999 Lippincott Williams & Wilkins, Inc., Philadelphia Journal of Neuro- Ophthalmology Volume 19, 1999 Subject Index Abducens nerve, palsy of, 252 Abducens paresis, diplopia and, 242 Acquired immune deficiency syndrome bilateral trochlear nerve palsy with cryptococcal meningitis in, 118 central nervous system cryptococcosis in, 131 cerebral infarction in ( abstract), 115 Adenosquamous carcinoma, of facial bones, skull base, and calvaria ( abstract), 113 Afferent pupillary defect, 17 in anisocoria, 153 Afferent visual system evaluation of, 17 pregeniculate, 207 African American patients, periocular depigmentation in after repeated botulinum toxin A injections, 7 Aging, cerebrovascular disease and ( abstract), 115 Alteplase infusion, for dural sinus thrombosis ( abstract), 117 Altitudinal field defect, cerebral metastasis with, 10 Anatomic variations, in hemianopsia, 136 Aneurysm, neck, magnetic resonance angiography of ( abstract), 116 Angiography, magnetic resonance ( abstract), 116 Anhidrosis, in Horner syndrome, 148 Anisocoria, small relative afferent pupillary defect in, 153 Announcements, 152, 218 Anti- Ri antibody, ophthalmoplegia with, 246 Antisaccades, after head injury, 160 Arabic population, microvascular cranial nerve palsies in, 252 Arachnoid cyst, of cavernous sinus, 249 Arteriovenous fistula, dural, of marginal sinus ( abstract), 117 Arteriovenous malformation cerebral, radiologic parameters in ( abstract), 117 orbital dural, 46 Arteritic ischemic optic neuropathy, magnetic resonance imaging in, 235 Astrocytoma, neuro- ophthalmologic manifestations of, 62 Autoantibody, in optic nerve and retinal disease, 71 Axonal loss, in atypical idiopathic intracranial hypertension, 182 Babesiosis, visual system effects of, 263 Band optic atrophy, 207 Bartonellosis, presumed ocular ( abstract), 260 Bedside tests, of saccades after head injury, 160 Bioimplant, CT- generated porous hydroxyapatite orbital floor ( abstract), 113 Blepharoplasty, lower lid, 176 Blepharospasm, essential, botulinum toxin A injections for, 7 Blood supply, in posterior optic nerve infarction, 176 Book reviews, 40, 109, 261 Books in brief, 111 Botox, periocular depigmentation after, 7 Botulinum toxin injections necrotizing fasciitis with ( abstract), 39 periocular depigmentation after, 7 Brachial avulsion, in Horner syndrome, 148 Brain heterotopic, in pterygopalatine fossa ( abstract), 113 injury of, bedside tests of saccades after, 160 Calcarine area changes, with retinal degeneration ( abstract), 112 Calvaria, adenosquamous carcinoma of ( abstract), 113 Cancer- associated retinopathy, 207 Carotid artery, internal aneurysm of in ocular neuromyotonia with tonic pupil, 125 dissection of, 136 Case series, of familial nonarteritic anterior ischemic optic neuropathy, 144 Cat- scratch disease, neuroretinitis and peripheral facial palsy with, 240 Cavernous sinus, arachnoid cysts of, 249 Central nervous system cryptococcosis of, wall- eyed bilateral internuclear ophthalmoplegia in, 131 lymphoma of, MR appearance of ( abstract), 114 multifocal involvement of in Langerhans cell histiocytosis, 49 Central retinal artery occlusion, intra- arterial fibrinolysis in ( abstract), 260 Cerebellar dysfunction, opsoclonus with, 229 Cerebral arteriovenous malformations, radiologic parameters in ( abstract), 117 Cerebral infarction, in AIDS ( abstract), 115 Cerebral metastasis, with altitudinal field defect, 10 Cerebral polyopia, with extrastriate quadrantanopia, 1 Cerebrospinal fluid papilledema, 222 Cerebrovascular disease aging and ( abstract), 115 with AIDS ( abstract), 115 Cervicocranial arteries, dissecting aneurysm of ( abstract), 117 Chiropractic neck manipulation, cerebral polyopia after, 1 Chondrosarcoma, neuro- ophthalmologic manifestations of, 62 Choroidal neovascular membrane, clinicopathological correlation of in pseudotumor cerebri ( abstract), 39 Choroiditis, 201 Chronic inflammatory demyelinating polyneuropathy, optic atrophy in, 67 Clinicoanatomic correlations ( abstract), 112 Coats disease, proton MR spectroscopy in ( abstract), 112 Coil embolization, for dissecting aneurysm of cervicocranial arteries ( abstract), 117 Complications, lower lid blepharoplasty, 176 Congenital optic tract syndrome, 17 Convergence cryptococcosis, 131 Convergence- evoked pendular nystagmus, in multiple sclerosis, 34 Cortical plasticity, visual field defects and, 84 Cranial nerves inferior division third, paresis of, 46 microvascular palsy of, in Arabic population, 252 Craniocervical dystonia, botulinum toxin A injections for, 7 Creutzfeldt- Jakob disease, 207 Cryptococcal meningitis, bilateral trochlear nerve palsy with, 118 Cryptococcosis, central nervous system, 131 Cyclopia, craniofacial appearance in ( abstract), 112 Cystic pituitary mass, in neurosarcoidosis ( abstract), 114 Demyelinating polyneuropathy, chronic inflammatory, 67 Depigmentation, periocular, prevalence of after repeated botulinum toxin A injections, 7 Diabetes, in cranial nerve palsies, 252 DIDMOAD syndrome, optic atrophy in ( abstract), 39 Diplopia in Maffucci's syndrome and Ollier's disease, 62 nonlocalizing cause of, 242 transient vertical, 173 in trochlear nerve palsy, 118 Dissecting aneurysms, of cervicocranial arteries in fibromuscular dysplasia ( abstract), 117 Divergence paresis, diplopia and, 242 Dopamine, in toxic optic neuropathy, 232 Down syndrome, latent and congenital nystagmus in, 166 278 SUBJECT INDEX 279 Dural fistula arteriovenous, of marginal sinus ( abstract), 117 cavernous, embolization of ( abstract), 116 Dural sinus thrombosis, endovascular thrombolytic therapy for ( abstract), 117 Ehrlichiosis, visual system effects of, 263 Embolization, of dural cavernous fistulas ( abstract), 116 Enchondroma, multiple, 62 Endoscopic sinus surgery, for mucormycosis, 56 Endovascular stents, for dissecting aneurysm of cervicocranial arteries ( abstract), 117 Endovascular treatment of ophthalmic segment aneurysms ( abstract), 116 thrombolytic, for dural sinus thrombosis ( abstract), 117 Environmental rotation, with ventriculoperitoneal shunt, 13 Ephaptic transmission, in ocular neuromyotonia with tonic pupil, 125 Exophthalmos, third nerve paresis and, 46 Extrastriate quadrantanopia, cerebral polyopia with, 1 Eye disease 22- kDa antigen in, 71 thyroid, 54 Eye movements, after head injury, 160 Eyelid retraction, in thyroid orbitopathy, 122 Facial bones, adenosquamous carcinoma of ( abstract), 113 Facial palsy, peripheral, in cat- scratch disease, 240 Familial nonarteritic anterior ischemic optic neuropathy, occurrence of, 144 Fatigue, ptosis in, 257 Fibromuscular dysplasia, dissecting aneurysm of cervicocranial arteries in ( abstract), 117 Filling- in, perceptual, 84 Functional magnetic resonance imaging, in visual system, 186 Gaze palsy, reversible, disseminated histoplasmosis in, 140 Geniculate nucleus metastasis, 17 Giant cell arteritis, 17, 207 Horner syndrome due to ( abstract), 260 Glaucoma, perimetry for, 100 Globe tenting, in head trauma ( abstract), 112 Graves' disease, ocular manifestations of, 54 Guglielmi detachable coils, in endovascular treatment of ophthalmic segment aneurysms ( abstract), 116 Hantavirus, visual system effects of, 263 Head injury of, bedside tests of saccades after, 160 lesions of, scintigraphy for ( abstract), 113 neoplasms of, dynamic contrast- enhanced gradient- echo and spin- echo MR of ( abstract), 113 trauma to, globe tenting with ( abstract), 112 Hemianopsia, in dissection of internal carotid artery, 136 Hemifacial spasm botulinum toxin A injections for, 7 neurointerventional diagnosis of ( abstract), 116 Hemorrhagic arachnoid cyst, with third nerve paresis ( abstract), 114 High altitude retinopathy, 205 Histiocytosis, Langerhans cell, visual loss with, 49 Histopathology, optic nerve, 182 Histoplasma capsulatum, in reversible gaze palsy and optic neuropathy, 140 Histoplasmosis, disseminated, in reversible gaze palsy and optic neuropathy, 140 Homonymous hemianopsia as initial manifestation of multiple sclerosis ( abstract), 39 in pediatric patients, 17 Horner syndrome due to giant cell arteritis ( abstract), 260 without anhidrosis, traumatic, 148 Human immunodeficiency virus infection bilateral trochlear nerve palsy with cryptococcal meningitis in, 118 visual loss with, 207 Humphrey field analyzer, in perimetry, 89 Hydrocephalus, ventriculoperitoneal shunt for, 13 Hydroxyapatite orbital floor prosthesis, CT- generated porous ( abstract), 113 Infections, emerging and re- emerging, 263 Internuclear ophthalmoplegia, wall- eyed bilateral, 131 Intra- ai'terial fibrinolysis, stage- dependent efficacy of in central retinal artery occlusion ( abstract), 260 Intracranial aneurysms, 17 Intracranial disease ( abstract), 114 Intracranial fatigable ptosis, 257 Intracranial hypertension atypical idiopathic, 182 idiopathic, 17, 207 Intracranial imaging, in Sturge- Weber syndrome ( abstract), 114 Intracranial infections, fast fluid- attenuated inversion- recovery MR of ( abstract), 114 Intracranial vascular stenosis/ occlusion, magnetic resonance angiography of ( abstract), 116 Ischemic optic neuropathy anterior, 17 arteritic, magnetic resonance imaging in, 235 Langerhans cell histiocytosis, visual loss with, 49 Lateral geniculate hemorrhage, traumatic, 207 Leber's hereditary optic neuropathy, 17, 207 with mtDNA 14484 mutation, 28 orbital magnetic resonance imaging in, 238 perimetry for, 89 Letters to editor, 120, 217 Literature abstracts, 112, 260 European, 39 Lyme disease, visual system effects of, 263 Lymphatic capillaries, in meninges of human optic nerve, 222 Lymphoma, central nervous system, MR appearance of ( abstract), 114 Macular neuroretinopathy, acute, 17 Macular star, in neuroretinitis, 201 Maffucci's syndrome, neuro- ophthalmologic manifestations of, 62 Magnetic resonance angiography for intracranial vascular stenosis and occlusion ( abstract), 116 of neck aneurysm models ( abstract), 116 Magnetic resonance imaging of activated areas of visual cortex ( abstract), 112 in afferent visual system evaluation, 17 for arachnoid cysts of cavernous sinus, 249 in arteritic ischemic optic neuropathy, 235 changes in calcarine area with retinal degeneration ( abstract), 112 in Coats disease ( abstract), 112 for cyclopia ( abstract), 112 fast fluid- attenuated inversion- recovery ( abstract), 114 functional, in visual system, 186 of head and neck neoplasms ( abstract), 113 for Langerhans cell histiocytosis, 49 in Leber's hereditary optic neuropathy, 238 in multiple sclerosis with various disability levels ( abstract), 115 of primary lymphoma of central nervous system ( abstract), 114 of squamous cell carcinoma ( abstract), 113 with visual field deficits ( abstract), 112 Magnetic resonance pulse sequences, in multiple sclerosis ( abstract), 114 Magnetization transfer imaging in multiple sclerosis ( abstract), 115 single- dose gadolinium versus triple- dose gadolinium ( abstract), 115 Marginal sinus, dural arteriovenous fistula of ( abstract), 117 Melanin, botulinum toxin A injections and, 7 Melatonin, in toxic optic neuropathy, 232 Memory- guided saccades, after head injury, 160 Meninges, lymphatic capillaries of, 222 Meningioma, 207 Meningitis, cryptococcal, bilateral trochlear nerve palsy with, 118 J Neuro- Ophthalmol, Vol. 19, No. 4, 1999 280 SUBJECT INDEX Mercury poisoning, visual field deficits with ( abstract), 112 Metastasis, cerebral, with altitudinal field defect, 10 Microvascular cranial nerve palsies, in Arabic population, 252 Midbrain, in fatigable ptosis, 257 Minamata disease, visual field deficits with ( abstract), 112 Miosis, in Horner syndrome, 148 Motor neuropathy, multifocal, 67 mtDNA 14484 mutation, multiple sclerosis- like illness with, 28 Mucormycosis, endoscopic sinus surgery for, 56 Multifocal motor neuropathy, optic atrophy in, 67 Multiple sclerosis acquired convergence- evoked pendular nystagmus in, 34 computer- assisted quantitation of enhancing lesions in ( abstract), 115 global volumetric estimation of disease burden in ( abstract), 115 homonymous hemianopsia as manifestation of ( abstract), 39 magnetic resonance pulse sequences in ( abstract), 114 MR detection of lesions in ( abstract), 115 serial contrast- enhanced MR with varying levels of disability in ( abstract), 115 Multiple sclerosis- like illness, with mtDNA 14484 mutation, 28 NAION, 207 familial, occurrence of, 144 NANOS, history of, 219 Neck aneurysm of, magnetic resonance angiography of ( abstract), 116 lesions of, scintigraphy for ( abstract), 113 neoplasms of, dynamic contrast- enhanced gradient- echo and spin- echo MR of ( abstract), 113 Necrotizing fasciitis, with botulinum toxin injection ( abstract), 39 Neonatal onset multisystem inflammatory disease, optic disc edema in, 180 Neoplasms head and neck, dynamic contrast- enhanced gradient- echo and spin- echo MR of ( abstract), 113 visual pathway, 207 Neurointerventional techniques, in hemifacial spasm diagnosis ( abstract), 116 Neuromyotonia, ocular, with tonic pupil, 125 Neuropathy, optic, 22- kDa antigen in, 71 Neuroradiology, interventional ( abstract), 116 Neuroretinitis in cat- scratch disease, 240 tuberculous, 201 Neurosarcoidosis, cystic pituitary mass in ( abstract), 114 Neurovascular disease, covered stent placement for ( abstract), 116 NOMID, optic disc edema in, 180 Null cell adenoma, 128 Nystagmus acquired convergence- evoked pendular, in multiple sclerosis, 34 in Down syndrome, 166 see- saw, 207 Objective pupil perimetry, versus threshold visual perimetry, 89 Occipital infarction, hemianopsia in, 136 Ocular microtremor, in oculomotor palsy, 42 Ocular neuromyotonia, with tonic pupil, 125 Oculomotor nerve palsy, 252 ocular microtremor in, 42 in ocular neuromyotonia with tonic pupil, 125 Oilier's disease, neuro- ophthalmologic manifestations of, 62 Ophthalmic segment aneurysms, endovascular treatment of ( abstract), 116 Ophthalmic vein, superior, third nerve paresis and, 46 Ophthalmoplegia, with anti- Ri antibody, 246 Opsoclonus, with cerebellar dysfunction, 229 Opsoclonus- myoclonus- ataxis, anti- Ri antibody and, 246 Optic atrophy in chronic acquired polyneuropathy, 67 in Wolfram syndrome ( abstract), 39 Optic chiasm evaluation of, 17, 207 in Langerhans cell histiocytosis, 49 Optic disc edema in neonatal onset multisystem inflammatory disease, 180 in neuroretinitis, 201 Optic nerve enhancement of on magnetic resonance imaging in arteritic ischemic optic neuropathy, 235 on orbital magnetic resonance imaging in Leber hereditary optic neuropathy, 238 evaluation of, 207 histopathology of, 182 infarction of, 17 22- kDa antigen in disease of, 71 in Langerhans cell histiocytosis, 49 lymphatic capillaries in meninges of, 222 neuro- ophthalmology of, 17 Optic nerve infarction, posterior, after lower lid blepharoplasty, 176 Optic neuritis, 17, 207 Optic neuropathy anterior ischemic, 207 arteritic ischemic, magnetic resonance imaging in, 235 disseminated histoplasmosis in, 140 familial nonarteritic anterior ischemic, 144 glaucomatous and nonglaucomatous, 100 infectious, inflammatory, and postsurgical, 207 infectious causes of, 17 infiltrative, 49 Leber's hereditary, 17, 207 with mtDNA 14484 mutation, 28 orbital magnetic resonance imaging in, 238 perimetry for, 89 perimetry for, 100 toxic, after melatonin, zoloft, and high- protein diet, 232 Optic tract infarction of, 17 metastasis to, 17 Orbital dural arteriovenous malformation, inferior division third nerve paresis from, 46 Orbital fissure, superior, third nerve paresis and, 46 Orbital floor prosthesis, CT- generated porous hydroxyapatite ( abstract), 113 Pallidotomy, 17 Papilledema, cerebrospinal fluid, 222 Paraganglioma, atypical skull base ( abstract), 113 Paresis, divergence, 242 Parietal cortex, posterior, disordered inputs to, 13 Pathologic correlations ( abstract), 112 Peak count, for ocular microtremor in oculomotor palsy, 42 Pediatric patients, homonymous hemianopsia in, 17 Pendular nystagmus, convergence- evoked, 34 Perceptual filling- in, in unawareness of visual field defects, 84 Perimetry automated, 100 threshold visual versus objective pupil, 89 Periocular depigmentation, prevalence of after repeated botulinum toxin A injections, 7 Peripheral facial palsy, in cat- scratch disease, 240 Piezoelectric strain gauge, for ocular microtremor, 42 Pituitary adenoma of, 128, 207 apoplexy of, 17 Plasmacytoma, craniocerebral ( abstract), 114 Pneumocephalus, 128 Polyneuropathy, chronic acquired, 67 Pregeniculate afferent visual system, neuro- ophthalmology of, 17, 207 Prosthesis, CT- generated porous hydroxyapatite orbital floor ( abstract), 113 J Neuro- Ophthalmol, Vol. 19. No. 4, 1999 SUBJECT INDEX 281 Protein diet, in toxic optic neuropathy, 232 Proton magnetic resonance spectroscopy in Coats disease ( abstract), 112 of squamous cell carcinoma ( abstract), 113 Pseudotumor cerebri, clinicopathological correlation of excised choroidal neovascular membrane in ( abstract), 39 Pterygopalatine fossa, heterotopic brain in ( abstract), 113 Ptosis in Horner syndrome, 148 intracranial fatigable, 257 Pulfrich phenomenon, 17, 207 symptoms and management of, 12 Pupil in anisocoria, 153 perimetry of versus threshold visual perimetry, 89 Quadrantanopia, extrastriate, cerebral polyopia with, 1 Radiation therapy, for Langerhans cell histiocytosis, 49 Radiosurgery, predicting response to ( abstract), 117 Retina degeneration of, MR changes in calcarine area with ( abstract), 112 22- kDa antigen in disease of, 71 neuro- ophthalmology and, 17, 207 vascular disease and, 207 in visual field defects, 84 Retinal detachment exudative, 201 serous, 201 Retinopathy cancer- associated, 207 high altitude, 205 22- kDa antigen in, 71 non- cancer- associated, 71 Rhino- orbital mucormycosis, endoscopic sinus surgery for, 56 Rhino- orbito- cerebral mucormycosis, endoscopic sinus surgery for, 56 Saccades, after head injury, 160 Scintigraphy, of head and neck lesions ( abstract), 113 Self- paced saccades, after head injury, 160 Sellar arachnoid cysts, 207 Sertraline, in toxic optic neuropathy, 232 Silent sinus syndrome, transient diplopia and, 173 Sinus disorders, transient diplopia and, 173 Sinus surgery, for mucormycosis, 56 Skeletal enchondromas, multiple, 62 Skull base adenosquamous carcinoma of ( abstract), 113 atypical paragangliomas of ( abstract), 113 Sneeze, perils in, 128 Spectroscopy, proton magnetic resonance in Coats disease ( abstract), 112 in squamous cell carcinoma ( abstract), 113 Squamous cell carcinoma, proton MR spectroscopy of ( abstract), 113 Stents for dissecting aneurysm of cervicocranial arteries ( abstract), 117 placement of for neurovascular disease ( abstract), 116 Stereotactic radiosurgery ( abstract), 117 Striate cortex, visual field representations in ( abstract), 112 Sturge- Weber syndrome, abnormal ocular enhancement in ( abstract), 114 Subarachnoid space, lymphatic capillaries in, 222 Suprasellar extramedullary hematopoiesis, 17 Surgery, endoscopic sinus, 56 Surgical ligation, for dissecting aneurysm of cervicocranial arteries ( abstract), 117 Sweating, normal in Horner syndrome, 148 Syphilis, visual system effects of, 263 Systemic disease ophthalmic manifestations of ( abstract), 114 with visual system effects, 263 Tamoxifen retinopathy, 207 Terson syndrome, 17 Test- retest analysis, with functional magnetic resonance of activated visual cortex ( abstract), 112 Third nerve palsy of, with arachnoid cysts of cavernous sinus, 249 paresis of hemorrhagic arachnoid cyst with ( abstract), 114 inferior division, 46 Three- dimensional computed tomography, for cyclopia ( abstract), 112 Threshold visual perimetry, versus objective pupil perimetry, 89 Thrombolytic therapy, for dural sinus thrombosis ( abstract), 117 Thyroid eye disease, early, 54 Thyroid orbitopathy, spontaneous resolution of upper eyelid retraction in, 122 Tonic pupil, ocular neuromyotonia with, 125 Toxic optic neuropathy, after melatonin, Zoloft, and high- protein diet, 232 Transient vertical diplopia, silent sinus disorders and, 173 Trauma brain injury in, bedside tests of saccades after, 160 Horner syndrome without anhidrosis in, 148 lateral geniculate hemorrhage with, 207 Trochlear nerve palsy, 252 bilateral, 118 Troxler's phenomenon, 84 Tuberculous neuroretinitis, 201 Tumor, metastatic to optic tract, 17 22- kDa antigen, in optic nerve and retinal diseases, 71 Vascular anomalies, intracranial, 17 Vascular disease, retina and, 207 Vascular risk factors, in cranial nerve palsy, 252 Vascular stenosis, magnetic resonance angiography of ( abstract), 116 Ventriculoperitoneal shunt in atypical idiopathic intracranial hypertension, 182 visual environmental rotation after, 13 Visiospatial integration, disorders of, 13 Visual allesthesia, 13 Visual cortex magnetic resonance imaging of activated areas of ( abstract), 112 T2 shortening in ( abstract), 115 Visual environmental rotation, 13 Visual field 30- 2 versus 24- 2, 100 defects of, unawareness of, 84 loss of, pallidotomy and, 17 perimetry for, 89 representation of in striate cortex ( abstract), 112 testing of, 17, 207 Visual loss after lower lid blepharoplasty, 176 in atypical idiopathic intracranial hypertension, 182 HIV- associated, 207 with Langerhans cell histiocytosis, 49 with mtDNA 14484 mutation, 28 Visual pathway, multifocal involvement of in Langerhans cell histiocytosis, 49 Visual system emerging and re- emerging infections affecting, 263 functional magnetic resonance imaging in, 186 pregeniculate afferent, 17 problems of with Pulfrich phenomenon, 12 Wall- eyed bilateral internuclear ophthalmoplegia, 131 Whipple's disease, visual system effects of, 263 Willis, circle of, 136 Wolfram syndrome, optic atrophy in ( abstract), 39 Zoloft, in toxic optic neuropathy, 232 J Neuro- Ophlhalmol, Vol. 19, No. 4, 1999 |